Expert Review of Pharmacoeconomics & Outcomes Research, Volume 17, Issue 2 (2017)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Review of Pharmacoeconomics & Outcomes Research, Volume 17, Issue 2 (2017)

See all volumes and issues
Vol 24, 2024 Vol 23, 2023 Vol 22, 2022 Vol 21, 2021 Vol 20, 2020 Vol 19, 2019 Vol 18, 2018 Volume 17, 2017 Vol 16, 2016 Vol 15, 2015 Vol 14, 2014 Vol 13, 2013 Vol 12, 2012 Vol 11, 2011 Vol 10, 2010 Vol 9, 2009 Vol 8, 2008 Vol 7, 2007 Vol 6, 2006 Vol 5, 2005 Vol 4, 2004 Vol 3, 2003 Vol 2, 2002 Vol 1, 2001
Download citations Download PDFs Download issue

Drug Profile

Article
Cost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications
Gustavo Laine Araujo De Oliveira, Augusto Afonso Guerra Júnior, Brian Godman & Francisco de Assis Acurcio
Pages: 109-119
Published online: 22 Feb 2017
AbstractforCost-effectiveness of vildagliptin for people with type 2 diabetes mellitus in Brazil; findings and implications | Full Text | References | PDF (932.1 KB)
  • 288 Views
  • 13 CrossRef citations
  • 0Altmetric

Clinical Trial Report

Article
Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype
Anirban Basu, Anand Dalal, Giorgio Walter Canonica, Mark Forshag, Steven W. Yancey, Saurabh Nagar & Christopher F. Bell
Pages: 121-131
Published online: 17 Mar 2017
AbstractforEconomic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype | Full Text | References | PDF (1,019.9 KB)
  • 922 Views
  • 16 CrossRef citations
  • 0Altmetric

Perspective

Article
The value of open access and a patient centric approach to oral oncolytic utilization in the treatment of Chronic Myelogenous Leukemia: A U.S. perspective
Lopamudra Das, Matthew Gitlin, Lisa R. Siegartel & Dinara Makenbaeva
Pages: 133-140
Published online: 22 Mar 2017
AbstractforThe value of open access and a patient centric approach to oral oncolytic utilization in the treatment of Chronic Myelogenous Leukemia: A U.S. perspective | Full Text | References | PDF (868.9 KB)
  • 1845 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Article
Analysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support
N. López-Martínez, J.L. Segú, J. Vázquez-Castro, M. Brosa, L. Bohigas, M.J. Comellas & L. Kalfhaus
Pages: 141-148
Published online: 21 Feb 2017
AbstractforAnalysis of the implementation of a personalized care model in diabetes mellitus as an example of chronic disease with information and communication technology support | Full Text | References | PDF (1 MB) | Supplemental
  • 337 Views
  • 1 CrossRef citations
  • 0Altmetric

Meeting Report

Report
Outcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa
Amos Massele, Johanita Burger, Francis Kalemeera, Mary Jande, Thatayaone Didimalang, Aubrey Chichonyi Kalungia, Kidwell Matshotyana, Michael Law, Brighid Malone, Olayinka Ogunleye, Margaret Oluka, Bene D Paramadhas, Godfrey Rwegerera, Sekesai Zinyowera & Brian Godman
Pages: 149-152
Published online: 18 Nov 2016
AbstractforOutcome of the second Medicines Utilisation Research in Africa Group meeting to promote sustainable and appropriate medicine use in Africa | Full Text | References | PDF (432.4 KB)
  • 79 Views
  • 9 CrossRef citations
  • 0Altmetric

Review

Review
Utility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling
Jacqueline Brown, Keziah Cook, Kelly Adamski, Jocelyn Lau, Danielle Bargo, Sarah Breen & Anita Chawla
Pages: 153-164
Published online: 12 Apr 2017
AbstractforUtility values associated with advanced or metastatic non-small cell lung cancer: data needs for economic modeling | Full Text | References | PDF (1.5 MB) | Supplemental
  • 530 Views
  • 10 CrossRef citations
  • 0Altmetric
Review
Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications
Ioannis Petrakis, Ilias J Kyriopoulos, Alexandros Ginis & Kostas Athanasakis
Pages: 165-180
Published online: 17 Mar 2017
AbstractforLosing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications | Full Text | References | PDF (1.3 MB)
  • 816 Views
  • 39 CrossRef citations
  • 0Altmetric
Review
The unknown burden and cost of celiac disease in the U.S
Douglas Mogul, Yusuke Nakamura, Jaein Seo, Barri Blauvelt & John F P Bridges
Pages: 181-188
Published online: 12 Apr 2017
AbstractforThe unknown burden and cost of celiac disease in the U.S | Full Text | References | PDF (639.9 KB)
  • 460 Views
  • 7 CrossRef citations
  • 0Altmetric
Review
Direct and indirect cost of managing alzheimer’s disease and related dementias in the United States
Arijita Deb, James Douglas Thornton, Usha Sambamoorthi & Kim Innes
Pages: 189-202
Published online: 12 Apr 2017
AbstractforDirect and indirect cost of managing alzheimer’s disease and related dementias in the United States | Full Text | References | PDF (1.4 MB)
  • 1373 Views
  • 99 CrossRef citations
  • 0Altmetric

Original Research

Article
Mapping the relationship between clinical and quality-of-life outcomes in patients with ankylosing spondylitis
Tomas Mlcoch, Liliana Sedova, Jiri Stolfa, Monika Urbanova, David Suchy, Andrea Smrzova, Jitka Jircikova, Karel Pavelka & Tomas Dolezal
Pages: 203-211
Published online: 24 Jun 2016
AbstractforMapping the relationship between clinical and quality-of-life outcomes in patients with ankylosing spondylitis | Full Text | References | PDF (900.1 KB)
  • 296 Views
  • 8 CrossRef citations
  • 0Altmetric
Article
Impact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration
Pedro A. Laires, Jackson Tang, Chun Po Steve Fan, Zhiyi Li, Ying Qiu & Kristy Iglay
Pages: 213-220
Published online: 30 Jun 2016
AbstractforImpact of hypoglycemic events and HbA1c level on sulfonylurea discontinuation and down-titration | Full Text | References | PDF (744.2 KB) | Supplemental
  • 200 Views
  • 2 CrossRef citations
  • 0Altmetric
Article
Price comparison of high-cost originator medicines in European countries
Sabine Vogler, Nina Zimmermann & Zaheer-Ud-Din Babar
Pages: 221-230
Published online: 11 Oct 2016
AbstractforPrice comparison of high-cost originator medicines in European countries | Full Text | References | PDF (918.8 KB) | Supplemental
  • 602 Views
  • 17 CrossRef citations
  • 0Altmetric
Article
The impact of price-cap regulations on market entry by generic pharmaceutical firms
Wei Zhang, Huiying Sun, Daphne Guh & Aslam H. Anis
Pages: 231-238
Published online: 27 Dec 2016
AbstractforThe impact of price-cap regulations on market entry by generic pharmaceutical firms | Full Text | References | PDF (1.1 MB)
  • 251 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

How can physicians improve medication adherence and outcomes in dermatological conditions?
Jessica Q. Duong et al.
Review Article | Published online: 24 Jun 2024
Accounting for planetary boundaries in health economic evaluation
Wolf Rogowski
Comment | Published online: 21 Jun 2024
Preferences of people with diabetes for diabetes care in Germany: a discrete choice experiment
Markus Vomhof et al.
Article | Published online: 21 Jun 2024
Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curves
Mavis Obeng-Kusi et al.
Review Article | Published online: 18 Jun 2024
View all latest articles